Avi Tsafrir

Avi Tsafrir

Auto-generated profile, based on publicly available information

Avi Tsafrir

IVF Unit, Department of Obstetrics and Gynecology, Hadassah Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 April 2024 in Human Reproduction Update
Verified
Journal Article
Closed access
PDF file
AHAyala Hirsch
Ayala Hirsch
BRBruria Hirsh Raccah
Bruria Hirsh Raccah
R0Reut Rotem (ORCID - 0000-0002-4063-5911)
Reut Rotem (ORCID - 0000-0002-4063-5911)
JHJordana H Hyman
Jordana H Hyman
IBIdo Ben-Ami
Ido Ben-Ami
ATAvi Tsafrir
Avi Tsafrir
Awareness of the age-related decline in fertility potential has increased the popularity of planned oocyte cryopreservation (POC). However, data regarding outcomes of POC, including rates of women returning to thaw oocytes, as well as pregnancy and live birth rates, are scarce and based mostly on small case series. POC was defined as cryopreservation exclusively for prevention of future age-related fertility loss. The primary outcome was live birth rate per patient. The secondary outcomes included the return to thaw rate and laboratory outcomes. A meta-regression analysis examining the association between live birth and age above 40 or below 35 was conducted. We conducted a systematic database search from inception to August 2022. The search included PubMed (MEDLINE) and EMBASE. Our search strategies employed a combination of index terms (Mesh) and free text words to compile relevant concepts. The systematic review and meta-regression were undertaken following registration of systematic review (PROSPERO registration number CRD42022361791) and were reported following guidelines of Preferred Reporting Items for Systematic Review and Meta-Analyses 2020 (PRISMA 2020). The database search yielded 3847 records. After the selection process, 10 studies, conducted from 1999 to 2020, were included. Overall, 8750 women underwent POC, with a mean cryopreservation age of 37.2 (±0.8). Of those, 1517 women returned to use their oocytes with a return rate of 11.1% (± 4.7%). The mean age at the time of cryopreservation for women who returned to use their oocytes was 38.1 (±0.4), with an average of 12.6 (±3.6) cryopreserved oocytes per woman. In a meta-analysis, the oocyte survival rate was 78.5% with a 95% CI of 0.74–0.83 (I2 = 93%). The live birth rate per patient was 28% with a 95% CI of 0.24–0.33 (I2 = 92%). Overall, 447 live births were reported. In a sub-group analysis, women who underwent cryopreservation at age ≥40 achieved a live birth rate per patient of 19% (95% CI 0.13–0.29, I2 = 6%), while women aged ≤35 years old or younger had a higher live birth rate per patient of 52% (95% CI 0.41–0.63, I2 = 7%). POC emerges as a feasible option for women aiming to improve their chances of conceiving at a later reproductive age. Nonetheless, it must be acknowledged that the overall success rates of POC are limited and that the likelihood of successful live birth declines as the age at cryopreservation rises. With increasing interest in POC, the collation of comprehensive and high-quality data is imperative to clearly define the outcomes for various age groups. CRD42022361791. In meta-analysis, Planned Oocyte Cryopreservation yielded 28% live birth rate, strongly correlated with age at cryopreservation.

1 January 2007 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
ATA Tsafrir
A Tsafrir
ASA Simon
A Simon
ARAriel Revel
Ariel Revel
BRBenjamin Reubinoff
Benjamin Reubinoff
ALA Lewin
A Lewin
NLN Laufer
N Laufer

20 October 2022 in Journal of Assisted Reproduction and Genetics
Verified
Journal Article
Closed access
PDF file
ATAvi Tsafrir
Avi Tsafrir
IBIdo Ben-Ami
Ido Ben-Ami
TETalia Eldar-Geva
Talia Eldar-Geva
MGMichael Gal
Michael Gal
NDNava Dekel
Nava Dekel
JHJordana Hyman
Jordana Hyman

1 February 2021 in Reproductive BioMedicine Online
Verified
Journal Article
Closed access
TMTalya Miron-Shatz
Talya Miron-Shatz
HHHananel Holzer
Hananel Holzer
ARAriel Revel
Ariel Revel
AWAriel Weissman
Ariel Weissman
DTDanit Tarashandegan
Danit Tarashandegan
ATAvi Tsafrir
Avi Tsafrir

17 August 2015 in Gynecological Endocrinology
Verified
Journal Article
Closed access
PDF file
ATAvi Tsafrir
Avi Tsafrir
RHRonit Haimov-Kochman
Ronit Haimov-Kochman
EMEhud J. Margalioth
Ehud J. Margalioth
TETalia Eldar-Geva
Talia Eldar-Geva
MGMichael Gal
Michael Gal
DGDoron Goldberg
Doron Goldberg
Oocyte cryopreservation for age-related fertility loss is gaining interest considering the tendency to postpone motherhood in many societies. Little is currently known about the actual efficiency of this approach. We aimed to explore ovarian response of presumably fertile women undergoing in vitro fertilization for this indication. A total of 105 women underwent 151 stimulation cycles at mean age 37.7 ± 2.4. None had known infertility. Mean daily starting FSH dose was 371 ± 110 (225–600). Mean number of mature oocytes cryopreserved at the first completed cycle was 9.7 ± 7.5 (0–43). However, 21% of started cycles were either cancelled before egg retrieval or resulted in 0–3 mature oocytes retrieved. Therefore, women considering oocyte cryopreservation for prevention of age-related fertility decline should be encouraged to perform this procedure at younger age than, preferably before 35.

1 February 2007 in American Journal of Obstetrics and Gynecology
Verified
Journal Article
Closed access
ABAssaf Ben-Meir
Assaf Ben-Meir
TETamar Elram
Tamar Elram
ATAvi Tsafrir
Avi Tsafrir
UEUriel Elchalal
Uriel Elchalal
YEyossef ezra
yossef ezra